Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion type Assertion NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_head.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion description "[Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_provenance.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion evidence source_evidence_literature NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_provenance.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion SIO_000772 19009294 NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_provenance.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion wasDerivedFrom befree-20140225 NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_provenance.
- NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_assertion wasGeneratedBy ECO_0000203 NP802726.RAQCKqNZRz6uAsxM-7IlzFc359kH35fDyOd50MP4UlJrI130_provenance.